









Markets
/
Stocks
/
nasdaq-rdgt
/

RDGT

1.690USD

+0.110+7.10%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

9.89MMarket Cap

0.92P/E TTM



RDGT

1.690

+0.110+7.10%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of RDGT

Currency: USD Updated: 2026-02-06

Key Insights

Ridgetech Inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 25 out of 30 in the Food & Drug Retailing industry.Institutional ownership is low.In the medium term, the stock price is expected to trend down.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

RDGT's Score

Industry at a Glance

Industry Ranking

25 / 30

Overall Ranking

428 / 4521

Industry

Food & Drug Retailing

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

RDGT Highlights

StrengthsRisks

Ridgetech Inc, formerly China Jo-Jo Drugstores Inc, is a retailer and distributor of pharmaceutical and other healthcare products. The Company operates in four business segments. The Retail Drugstores segment sells prescription and over the counter (OTC) medicines, traditional Chinese medicine (TCM), dietary supplements, medical devices, and sundry items to retail customers. The Online Pharmacy segment sells OTC drugs, dietary supplements, medical devices and sundry items through its own and third-party platforms. The Wholesale Business segment includes supplying the Company's own retail drugstores and selling them to other drug vendors and hospitals. The Farming and Selling Herbs segment cultivates selected herbs for sales to other drug vendors.

Turnaround to Profit

The company's performance has turned profitable, with the latest annual net income of USD .

Undervalued

The company’s latest PE is 0.92, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 45.94K shares, decreasing 21.32% quarter-over-quarter.

Held by James Simons

Star Investor James Simons holds 0.00 shares of this stock.

Analyst Rating

Based on 0 analysts

Current Rating

0.000

Target Price

0.00%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of Ridgetech Inc is 6.64, ranking 23 out of 30 in the Food & Drug Retailing industry. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 71.16M, representing a year-over-year decrease of 9.44%, while its net profit experienced a year-over-year decrease of 146.37%.

Score

Industry at a Glance

Previous score

6.64

Change



Financials

5.52

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

2.73

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

9.38

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

8.22

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.37

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

RDGT's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of Ridgetech Inc is 8.22, ranking 11 out of 30 in the Food & Drug Retailing industry. Its current P/E ratio is 0.92, which is 9433.44% below the recent high of 87.60 and 100.00% above the recent low of 0.00.

Score

Industry at a Glance

Previous score

8.22

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 25/30

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

No earnings forecast score is currently available for Ridgetech Inc. The Food & Drug Retailing industry's average is 7.64.

Score

Industry at a Glance

Previous score

0.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

No Data

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of Ridgetech Inc is 6.42, ranking 24 out of 30 in the Food & Drug Retailing industry. Currently, the stock price is trading between the resistance level at 2.70 and the support level at 1.02, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.24

Change

0.18

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(2)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-0.085

Sell

RSI(14)

33.670

Neutral

STOCH(KDJ)(9,3,3)

21.171

Buy

ATR(14)

0.292

Low Volatility

CCI(14)

-50.614

Neutral

Williams %R

78.338

Sell

TRIX(12,20)

-2.380

Sell

StochRSI(14)

100.000

Overbought

Moving Average

Sell(5)

Neutral(0)

Buy(1)

Indicators

Value

Direction

MA5

1.556

Buy

MA10

1.767

Sell

MA20

2.202

Sell

MA50

3.016

Sell

MA100

2.544

Sell

MA200

1.841

Sell

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of Ridgetech Inc is 3.00, ranking 16 out of 30 in the Food & Drug Retailing industry. The latest institutional shareholding proportion is 0.25%, representing a quarter-over-quarter decrease of 68.29%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.00% of shares outstanding, with 1.00% increase in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Kong (Lingtao)

2.23M

Super Marvel, Ltd.

25.13K

HHLR Advisors, Ltd.

20.17K

Two Sigma Investments, LP

14.26K

+8.72%

Citadel Advisors LLC

11.51K

Zhao (Ming)

581.00

-82.56%

Gu (Genghua)

42.00

XTX Markets LLC

-100.00%

UBS Financial Services, Inc.

4.81K

-63.32%

Oarsman Capital Inc.

-100.00%

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Food & Drug Retailing domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Ridgetech Inc is 1.30, ranking 29 out of 30 in the Food & Drug Retailing industry. The company's beta value is -0.31. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.